Glycorex Transplantation AB (publ) (NGM:GTAB.B)
1.755
-0.015 (-0.85%)
At close: Nov 18, 2026
NGM:GTAB.B Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4.82 | 10.16 | 5.77 | 12.89 | 32.63 | 41.18 |
Short-Term Investments | 0.98 | 0.99 | 0.99 | 0.97 | 0.93 | 0.95 |
Cash & Short-Term Investments | 5.8 | 11.16 | 6.75 | 13.86 | 33.56 | 42.13 |
Cash Growth | -53.36% | 65.20% | -51.28% | -58.71% | -20.34% | -14.54% |
Accounts Receivable | 6.17 | 3.39 | 4.28 | 3.11 | 3.54 | 2.84 |
Other Receivables | - | 1.73 | 1.66 | 1.8 | 2.13 | 0.94 |
Receivables | 6.17 | 5.11 | 5.94 | 4.9 | 5.68 | 3.77 |
Inventory | 6.21 | 5.16 | 4.73 | 6.33 | 4.85 | 3.52 |
Prepaid Expenses | - | 1.15 | 1.07 | 1.04 | 1.35 | 1.13 |
Total Current Assets | 18.17 | 22.58 | 18.49 | 26.14 | 45.44 | 50.56 |
Property, Plant & Equipment | 18.12 | 12.34 | 12.66 | 17.14 | 12.75 | 10.95 |
Long-Term Deferred Charges | 14.44 | 15.88 | 19.15 | 22.57 | 37.89 | 40.3 |
Total Assets | 50.73 | 50.79 | 50.3 | 65.84 | 96.08 | 101.8 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | - | 1.13 | 1.33 | 1.54 | 2.99 | 1.13 |
Accrued Expenses | - | 5.08 | 5.17 | 5.68 | 5.26 | 5.36 |
Current Portion of Long-Term Debt | - | - | 0.28 | 0.62 | 0.62 | 0.62 |
Current Portion of Leases | 3.89 | 3.66 | 3.81 | 3.77 | 3.7 | 3.23 |
Other Current Liabilities | 10.93 | 3.01 | 3.6 | 2.92 | 3.25 | 3.19 |
Total Current Liabilities | 14.82 | 12.87 | 14.18 | 14.53 | 15.82 | 13.52 |
Long-Term Debt | - | - | - | 0.31 | 0.69 | 1.06 |
Long-Term Leases | 9.11 | 3.33 | 2.89 | 6.79 | 5.03 | 4.14 |
Long-Term Deferred Tax Liabilities | 0.06 | 0.06 | 0.12 | 0.18 | 0.18 | 0.12 |
Total Liabilities | 23.99 | 16.26 | 17.19 | 21.81 | 21.71 | 18.85 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 3.94 | 3.94 | 3.69 | 3.69 | 3.69 | 3.69 |
Additional Paid-In Capital | 128.65 | 128.65 | 119.76 | 119.76 | 119.76 | 119.76 |
Retained Earnings | -105.84 | -98.05 | -90.33 | -79.38 | -49.02 | -40.44 |
Comprehensive Income & Other | -0.01 | -0.01 | -0.01 | -0.03 | -0.07 | -0.06 |
Shareholders' Equity | 26.74 | 34.54 | 33.11 | 44.04 | 74.36 | 82.95 |
Total Liabilities & Equity | 50.73 | 50.79 | 50.3 | 65.84 | 96.08 | 101.8 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 13 | 6.99 | 6.98 | 11.49 | 10.04 | 9.05 |
Net Cash (Debt) | -7.21 | 4.17 | -0.23 | 2.37 | 23.52 | 33.08 |
Net Cash Growth | - | - | - | -89.94% | -28.89% | -17.22% |
Net Cash Per Share | -0.09 | 0.05 | -0.00 | 0.03 | 0.32 | 0.45 |
Filing Date Shares Outstanding | 78.85 | 78.85 | 78.85 | 73.85 | 73.85 | 73.85 |
Total Common Shares Outstanding | 78.85 | 78.85 | 73.85 | 73.85 | 73.85 | 73.85 |
Working Capital | 3.35 | 9.71 | 4.31 | 11.61 | 29.62 | 37.04 |
Book Value Per Share | 0.34 | 0.44 | 0.45 | 0.60 | 1.01 | 1.12 |
Tangible Book Value | 26.74 | 34.54 | 33.11 | 44.04 | 74.36 | 82.95 |
Tangible Book Value Per Share | 0.34 | 0.44 | 0.45 | 0.60 | 1.01 | 1.12 |
Machinery | - | 16.94 | 16.89 | 17.16 | 14.1 | 13.38 |